Randomized phase III trial in MMR deficient endometrial cancer patients comparing chemotherapy alone versus Dostarlimab in first line advanced/metastatic setting
Trial Number
NCT05201547 (ClinicalTrials.gov Identifier)Contact Person
Status
Recruiting
Disease Site
Endometrial
Lead Cooperative Group
Participating Groups
AGO
GEICO
MaNGO
MITO
BGOG
PMHC
ANZGOG
KGOG